Vaccine-induced immune response to omicron wanes substantially over time
COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection
19 July 2022Study reveals impact of alcohol packaging on young people
19 July 2022Vaccine-induced immune response to omicron wanes substantially over time
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data. The findings, published today in Cell Reports Medicine, are from a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial was led by NIAID’s Infectious Diseases Clinical Research Consortium.
